Orange Book product · Generic (ANDA)
SODIUM ACETATE
SODIUM ACETATE
At a glance
Mar 15, 2024
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 15, 2024
2 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
SODIUM ACETATE
Strength
40MEQ/20ML (2MEQ/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 216920
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SODIUM ACETATE
- 1983SODIUM ACETATEBrand (NDA)
NDA 018893 · HOSPIRA
- 2026SODIUM ACETATEGeneric (ANDA)
ANDA 220274 · EXTROVIS
- 2026SODIUM ACETATEGeneric (ANDA)
ANDA 218469 · AMNEAL
- 2025SODIUM ACETATEGeneric (ANDA)
ANDA 219826 · SOMERSET THERAPS LLC
- 2024SODIUM ACETATEGeneric (ANDA)
ANDA 214805 · MILLA PHARMS
- 2017SODIUM ACETATEGeneric (ANDA)
ANDA 206687 · FRESENIUS KABI USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
